DIAM™ Spinal Stabilization System vs. Decompression, Formerly vs. Posterolateral Fusion
A Prospective, Randomized, Controlled Pivotal Clinical Investigation of DIAM™ Spinal Stabilization System in Patients With Degenerative Lumbar Spinal Stenosis.
Sponsor: Medtronic Spinal and Biologics
Terminated
slow patient recruitment
Listed as NCT00627497, this PHASE3 trial focuses on Degenerative Lumbar Spinal Stenosis and remains terminated or withdrawn. Sponsored by Medtronic Spinal and Biologics, it has been updated 8 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Feb 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Terminated PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Terminated PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE3
First recorded
Feb 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medtronic Spinal and Biologics
For direct contact, visit the study record on ClinicalTrials.gov .